In line with this hypothesis, our data evidently show that the radioresistance in vitro can be overcome by a co-targeting of JNK and β1 integrin, which also delayed tumor growth and increased survival of orthotopic GBM mice in vivo. This evidence concerns the gene MAPK8 and glioblastoma.